Chi-Fu Jeffrey Yang, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pneumonectomy | 53 | 2024 | 1128 | 8.680 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 68 | 2024 | 5388 | 7.920 |
Why?
|
Lung Neoplasms | 100 | 2024 | 13455 | 7.440 |
Why?
|
Thoracic Surgery, Video-Assisted | 16 | 2022 | 290 | 4.600 |
Why?
|
Neoplasm Staging | 73 | 2024 | 11208 | 3.890 |
Why?
|
Esophageal Neoplasms | 14 | 2023 | 1662 | 2.220 |
Why?
|
Esophagectomy | 12 | 2023 | 477 | 2.220 |
Why?
|
Small Cell Lung Carcinoma | 6 | 2023 | 452 | 2.050 |
Why?
|
Propensity Score | 16 | 2022 | 1967 | 1.430 |
Why?
|
Thymoma | 2 | 2022 | 185 | 1.310 |
Why?
|
Early Detection of Cancer | 10 | 2024 | 3237 | 1.300 |
Why?
|
Thymus Neoplasms | 2 | 2022 | 270 | 1.210 |
Why?
|
Pleural Neoplasms | 7 | 2023 | 583 | 1.190 |
Why?
|
Thoracic Surgery | 4 | 2023 | 728 | 1.130 |
Why?
|
Carcinoma, Squamous Cell | 9 | 2024 | 4046 | 1.030 |
Why?
|
Adenocarcinoma | 14 | 2024 | 6361 | 1.030 |
Why?
|
Retrospective Studies | 68 | 2024 | 81522 | 1.000 |
Why?
|
Radiosurgery | 5 | 2024 | 1328 | 0.990 |
Why?
|
Neoadjuvant Therapy | 13 | 2023 | 2894 | 0.940 |
Why?
|
Survival Rate | 28 | 2024 | 12821 | 0.920 |
Why?
|
Suicide | 3 | 2023 | 1606 | 0.880 |
Why?
|
Thymectomy | 2 | 2022 | 200 | 0.810 |
Why?
|
Mesothelioma | 4 | 2022 | 774 | 0.800 |
Why?
|
Tracheal Neoplasms | 2 | 2020 | 125 | 0.780 |
Why?
|
Chemotherapy, Adjuvant | 11 | 2023 | 3538 | 0.760 |
Why?
|
Humans | 151 | 2024 | 766011 | 0.720 |
Why?
|
Carcinoma, Adenoid Cystic | 2 | 2020 | 261 | 0.690 |
Why?
|
Databases, Factual | 15 | 2023 | 8062 | 0.690 |
Why?
|
Herpes Simplex | 1 | 2022 | 471 | 0.640 |
Why?
|
Thoracic Surgical Procedures | 3 | 2024 | 349 | 0.630 |
Why?
|
Esophageal Achalasia | 1 | 2020 | 99 | 0.630 |
Why?
|
Kaplan-Meier Estimate | 12 | 2024 | 6508 | 0.620 |
Why?
|
Thoracotomy | 5 | 2022 | 370 | 0.610 |
Why?
|
Coronavirus | 1 | 2020 | 155 | 0.590 |
Why?
|
Survival Analysis | 13 | 2024 | 10086 | 0.560 |
Why?
|
Robotics | 2 | 2022 | 808 | 0.560 |
Why?
|
Treatment Outcome | 35 | 2023 | 65236 | 0.550 |
Why?
|
Herpesvirus 1, Human | 1 | 2022 | 743 | 0.550 |
Why?
|
Aged | 59 | 2024 | 171233 | 0.540 |
Why?
|
Proportional Hazards Models | 14 | 2024 | 12520 | 0.540 |
Why?
|
Pulmonary Surgical Procedures | 1 | 2016 | 33 | 0.540 |
Why?
|
United States | 33 | 2024 | 72914 | 0.530 |
Why?
|
Middle Aged | 57 | 2024 | 223058 | 0.520 |
Why?
|
Frozen Sections | 1 | 2016 | 152 | 0.510 |
Why?
|
Lymphatic Metastasis | 4 | 2024 | 2883 | 0.500 |
Why?
|
Thoracoscopy | 2 | 2016 | 182 | 0.490 |
Why?
|
Hospitals, General | 1 | 2020 | 802 | 0.490 |
Why?
|
Parenteral Nutrition | 2 | 2011 | 661 | 0.490 |
Why?
|
Metformin | 1 | 2023 | 904 | 0.490 |
Why?
|
Lymph Nodes | 6 | 2023 | 3449 | 0.480 |
Why?
|
Male | 74 | 2024 | 363808 | 0.470 |
Why?
|
Eligibility Determination | 4 | 2024 | 422 | 0.460 |
Why?
|
Actigraphy | 1 | 2018 | 531 | 0.450 |
Why?
|
Pandemics | 7 | 2023 | 8699 | 0.440 |
Why?
|
Female | 71 | 2024 | 396159 | 0.440 |
Why?
|
Carcinoma, Small Cell | 1 | 2016 | 420 | 0.430 |
Why?
|
Time Factors | 15 | 2020 | 40117 | 0.420 |
Why?
|
Pneumothorax | 1 | 2016 | 392 | 0.420 |
Why?
|
Cranial Irradiation | 1 | 2016 | 384 | 0.420 |
Why?
|
Combined Modality Therapy | 10 | 2023 | 8531 | 0.410 |
Why?
|
Smoking | 4 | 2024 | 9082 | 0.410 |
Why?
|
Registries | 3 | 2021 | 8321 | 0.390 |
Why?
|
Cause of Death | 2 | 2019 | 3710 | 0.370 |
Why?
|
Multiple Pulmonary Nodules | 1 | 2023 | 170 | 0.370 |
Why?
|
Carcinoma, Neuroendocrine | 3 | 2019 | 340 | 0.370 |
Why?
|
Puerto Rico | 5 | 2019 | 380 | 0.370 |
Why?
|
Intention to Treat Analysis | 3 | 2021 | 416 | 0.350 |
Why?
|
Lung Transplantation | 1 | 2020 | 1311 | 0.350 |
Why?
|
Short Bowel Syndrome | 2 | 2011 | 352 | 0.340 |
Why?
|
Tomography, X-Ray Computed | 7 | 2024 | 20676 | 0.330 |
Why?
|
Secondary Prevention | 1 | 2016 | 1471 | 0.330 |
Why?
|
Radiotherapy, Adjuvant | 5 | 2022 | 1776 | 0.330 |
Why?
|
Antineoplastic Agents | 5 | 2019 | 13639 | 0.320 |
Why?
|
Carcinoma, Large Cell | 2 | 2019 | 114 | 0.310 |
Why?
|
Occupational Diseases | 2 | 2024 | 1456 | 0.310 |
Why?
|
Cohort Studies | 13 | 2024 | 41652 | 0.310 |
Why?
|
Mediastinum | 2 | 2023 | 271 | 0.300 |
Why?
|
Neoplasms | 3 | 2023 | 22350 | 0.300 |
Why?
|
Research | 1 | 2016 | 1974 | 0.300 |
Why?
|
SEER Program | 6 | 2021 | 1444 | 0.290 |
Why?
|
Prognosis | 15 | 2024 | 29915 | 0.290 |
Why?
|
Micronutrients | 1 | 2011 | 390 | 0.290 |
Why?
|
Postoperative Complications | 3 | 2022 | 15803 | 0.290 |
Why?
|
Enteral Nutrition | 2 | 2011 | 803 | 0.290 |
Why?
|
Education, Medical, Graduate | 1 | 2020 | 2418 | 0.290 |
Why?
|
Neoplasm Invasiveness | 4 | 2024 | 3599 | 0.280 |
Why?
|
Practice Guidelines as Topic | 3 | 2021 | 7426 | 0.270 |
Why?
|
Evidence-Based Medicine | 2 | 2015 | 3687 | 0.270 |
Why?
|
Anemia, Iron-Deficiency | 1 | 2011 | 374 | 0.270 |
Why?
|
Alanine Transaminase | 1 | 2009 | 608 | 0.260 |
Why?
|
Follow-Up Studies | 12 | 2020 | 39226 | 0.260 |
Why?
|
Behavior | 1 | 2009 | 535 | 0.250 |
Why?
|
Fingers | 1 | 2009 | 509 | 0.250 |
Why?
|
Intra-Aortic Balloon Pumping | 3 | 2012 | 222 | 0.250 |
Why?
|
Lymph Node Excision | 2 | 2023 | 1259 | 0.250 |
Why?
|
Tumor Burden | 2 | 2020 | 1889 | 0.250 |
Why?
|
Neoplasms, Second Primary | 1 | 2023 | 1056 | 0.250 |
Why?
|
Costs and Cost Analysis | 1 | 2021 | 1669 | 0.240 |
Why?
|
Men | 1 | 2005 | 65 | 0.230 |
Why?
|
Disease-Free Survival | 4 | 2019 | 6838 | 0.230 |
Why?
|
Patient Selection | 2 | 2016 | 4257 | 0.230 |
Why?
|
Liver Diseases | 2 | 2010 | 1303 | 0.220 |
Why?
|
Randomized Controlled Trials as Topic | 5 | 2024 | 10389 | 0.220 |
Why?
|
Lung | 6 | 2024 | 10031 | 0.220 |
Why?
|
Mental Disorders | 1 | 2023 | 6873 | 0.220 |
Why?
|
Space Perception | 1 | 2006 | 469 | 0.210 |
Why?
|
Brain Neoplasms | 2 | 2023 | 9071 | 0.210 |
Why?
|
Postoperative Period | 2 | 2019 | 1819 | 0.200 |
Why?
|
Fomites | 1 | 2022 | 15 | 0.200 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3099 | 0.200 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3222 | 0.200 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2018 | 3641 | 0.200 |
Why?
|
Biopsy | 4 | 2019 | 6766 | 0.190 |
Why?
|
Testosterone | 3 | 2009 | 2495 | 0.190 |
Why?
|
Counterpulsation | 2 | 2012 | 16 | 0.190 |
Why?
|
Vero Cells | 1 | 2022 | 481 | 0.190 |
Why?
|
Sarcoma | 1 | 2022 | 1801 | 0.190 |
Why?
|
Thoracic Outlet Syndrome | 1 | 2023 | 97 | 0.190 |
Why?
|
Cross-Cultural Comparison | 1 | 2005 | 635 | 0.190 |
Why?
|
Botulinum Toxins | 1 | 2023 | 191 | 0.190 |
Why?
|
Pericardial Effusion | 1 | 2023 | 246 | 0.180 |
Why?
|
Radiation | 1 | 2020 | 48 | 0.180 |
Why?
|
Pattern Recognition, Visual | 1 | 2006 | 820 | 0.180 |
Why?
|
Peristalsis | 1 | 2020 | 60 | 0.170 |
Why?
|
Esophagus | 4 | 2020 | 1037 | 0.170 |
Why?
|
Body Image | 1 | 2005 | 645 | 0.170 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2023 | 9371 | 0.160 |
Why?
|
Internship and Residency | 1 | 2020 | 5947 | 0.160 |
Why?
|
Risk Factors | 10 | 2023 | 74870 | 0.160 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2020 | 11862 | 0.160 |
Why?
|
Italy | 1 | 2021 | 851 | 0.160 |
Why?
|
Ontario | 1 | 2020 | 402 | 0.160 |
Why?
|
Adenocarcinoma, Bronchiolo-Alveolar | 1 | 2019 | 83 | 0.160 |
Why?
|
North Carolina | 2 | 2020 | 329 | 0.160 |
Why?
|
Aged, 80 and over | 8 | 2022 | 59526 | 0.150 |
Why?
|
Viruses | 1 | 2022 | 371 | 0.150 |
Why?
|
Sex Characteristics | 1 | 2009 | 2643 | 0.150 |
Why?
|
Oxidation-Reduction | 1 | 2024 | 2215 | 0.150 |
Why?
|
Patient Discharge | 1 | 2021 | 3466 | 0.150 |
Why?
|
Healthcare Disparities | 1 | 2023 | 3414 | 0.150 |
Why?
|
Musculoskeletal Diseases | 2 | 2024 | 598 | 0.150 |
Why?
|
Canada | 1 | 2023 | 2119 | 0.140 |
Why?
|
Esophagoscopy | 1 | 2019 | 398 | 0.140 |
Why?
|
Cytoskeleton | 1 | 2022 | 1178 | 0.140 |
Why?
|
Population Surveillance | 2 | 2019 | 2594 | 0.140 |
Why?
|
Occupational Health | 2 | 2024 | 813 | 0.140 |
Why?
|
Nomograms | 1 | 2019 | 235 | 0.140 |
Why?
|
Adult | 14 | 2023 | 223109 | 0.140 |
Why?
|
Advisory Committees | 1 | 2021 | 796 | 0.140 |
Why?
|
Happiness | 1 | 2018 | 173 | 0.130 |
Why?
|
Sarcopenia | 1 | 2021 | 378 | 0.130 |
Why?
|
Antioxidants | 1 | 2024 | 1670 | 0.130 |
Why?
|
Chest Tubes | 1 | 2016 | 153 | 0.130 |
Why?
|
NG-Nitroarginine Methyl Ester | 1 | 2016 | 261 | 0.130 |
Why?
|
Health Services Needs and Demand | 1 | 2023 | 1407 | 0.130 |
Why?
|
Feasibility Studies | 3 | 2022 | 5304 | 0.120 |
Why?
|
China | 2 | 2020 | 2387 | 0.120 |
Why?
|
Outpatients | 1 | 2023 | 1593 | 0.120 |
Why?
|
Virus Replication | 1 | 2022 | 2447 | 0.120 |
Why?
|
Mastectomy, Segmental | 1 | 2019 | 964 | 0.110 |
Why?
|
Immunotherapy | 5 | 2023 | 4752 | 0.110 |
Why?
|
Frail Elderly | 1 | 2019 | 785 | 0.110 |
Why?
|
Length of Stay | 3 | 2021 | 6492 | 0.110 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2024 | 2898 | 0.110 |
Why?
|
Professional Practice | 1 | 2015 | 313 | 0.110 |
Why?
|
Risk Assessment | 3 | 2019 | 24299 | 0.110 |
Why?
|
Genes, ras | 1 | 2016 | 656 | 0.110 |
Why?
|
Antiviral Agents | 2 | 2022 | 3051 | 0.110 |
Why?
|
Perioperative Care | 2 | 2024 | 1056 | 0.110 |
Why?
|
Respiratory Insufficiency | 1 | 2022 | 1241 | 0.100 |
Why?
|
Homeostasis | 1 | 2024 | 3335 | 0.100 |
Why?
|
Alcoholism | 1 | 2023 | 1977 | 0.100 |
Why?
|
Wavelet Analysis | 1 | 2012 | 56 | 0.100 |
Why?
|
Caregivers | 1 | 2024 | 2306 | 0.100 |
Why?
|
Multivariate Analysis | 2 | 2021 | 12060 | 0.100 |
Why?
|
Geriatric Assessment | 1 | 2019 | 1429 | 0.100 |
Why?
|
Patient Readmission | 2 | 2021 | 3286 | 0.100 |
Why?
|
Neuroendocrine Tumors | 1 | 2018 | 653 | 0.090 |
Why?
|
Incidence | 2 | 2023 | 21507 | 0.090 |
Why?
|
Recurrence | 1 | 2023 | 8505 | 0.090 |
Why?
|
Data Mining | 1 | 2015 | 561 | 0.090 |
Why?
|
Pneumonia | 1 | 2022 | 2156 | 0.090 |
Why?
|
Statistics, Nonparametric | 1 | 2015 | 2846 | 0.080 |
Why?
|
Saliva | 2 | 2022 | 851 | 0.080 |
Why?
|
Carbon Isotopes | 1 | 2010 | 451 | 0.080 |
Why?
|
Breath Tests | 1 | 2010 | 297 | 0.080 |
Why?
|
Logistic Models | 3 | 2018 | 13271 | 0.080 |
Why?
|
RNA, Messenger | 1 | 2024 | 12768 | 0.080 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2024 | 5336 | 0.080 |
Why?
|
Venous Thromboembolism | 1 | 2022 | 1882 | 0.080 |
Why?
|
Liver Function Tests | 1 | 2010 | 527 | 0.080 |
Why?
|
Pulmonary Embolism | 1 | 2022 | 2600 | 0.070 |
Why?
|
Methionine | 1 | 2010 | 569 | 0.070 |
Why?
|
Sepsis | 1 | 2022 | 2602 | 0.070 |
Why?
|
Odds Ratio | 2 | 2020 | 9654 | 0.070 |
Why?
|
Exercise | 1 | 2024 | 5937 | 0.070 |
Why?
|
Mass Screening | 3 | 2024 | 5448 | 0.070 |
Why?
|
Cisplatin | 2 | 2024 | 1656 | 0.070 |
Why?
|
Carbon Dioxide | 1 | 2010 | 1136 | 0.060 |
Why?
|
Intestinal Diseases | 1 | 2010 | 506 | 0.060 |
Why?
|
Quality of Life | 2 | 2024 | 13470 | 0.060 |
Why?
|
Cross-Sectional Studies | 2 | 2023 | 26283 | 0.060 |
Why?
|
Models, Cardiovascular | 1 | 2011 | 979 | 0.060 |
Why?
|
Somatotypes | 1 | 2005 | 39 | 0.060 |
Why?
|
Coronary Circulation | 1 | 2011 | 1602 | 0.060 |
Why?
|
Body Height | 1 | 2011 | 1561 | 0.060 |
Why?
|
Aorta, Thoracic | 1 | 2011 | 1110 | 0.060 |
Why?
|
Salivary Glands | 1 | 2006 | 231 | 0.060 |
Why?
|
Psychological Tests | 1 | 2006 | 643 | 0.060 |
Why?
|
Laparoscopy | 1 | 2016 | 2038 | 0.060 |
Why?
|
Anthropometry | 1 | 2009 | 1339 | 0.060 |
Why?
|
Hemodynamics | 2 | 2011 | 4190 | 0.050 |
Why?
|
Taiwan | 1 | 2005 | 522 | 0.050 |
Why?
|
Age Factors | 2 | 2019 | 18384 | 0.050 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2020 | 8927 | 0.050 |
Why?
|
Forecasting | 1 | 2012 | 2938 | 0.050 |
Why?
|
Hospitalization | 1 | 2023 | 10807 | 0.050 |
Why?
|
Fathers | 1 | 2006 | 377 | 0.050 |
Why?
|
5' Untranslated Regions | 1 | 2024 | 255 | 0.050 |
Why?
|
Medicare | 1 | 2021 | 6821 | 0.050 |
Why?
|
Vitamins | 1 | 2011 | 1632 | 0.050 |
Why?
|
Anabolic Agents | 1 | 2005 | 256 | 0.050 |
Why?
|
Sleep | 1 | 2018 | 4823 | 0.050 |
Why?
|
Pleura | 1 | 2023 | 241 | 0.050 |
Why?
|
Somatoform Disorders | 1 | 2005 | 425 | 0.050 |
Why?
|
Telephone | 1 | 2024 | 627 | 0.040 |
Why?
|
Animals | 7 | 2024 | 168721 | 0.040 |
Why?
|
Personal Satisfaction | 1 | 2005 | 641 | 0.040 |
Why?
|
Body Weight | 1 | 2011 | 4624 | 0.040 |
Why?
|
Heart-Assist Devices | 1 | 2011 | 1297 | 0.040 |
Why?
|
Sex Factors | 1 | 2023 | 10605 | 0.040 |
Why?
|
Attitude of Health Personnel | 1 | 2023 | 3926 | 0.040 |
Why?
|
State Medicine | 1 | 2021 | 219 | 0.040 |
Why?
|
Swine, Miniature | 2 | 2012 | 971 | 0.040 |
Why?
|
Multicenter Studies as Topic | 1 | 2024 | 1731 | 0.040 |
Why?
|
Comparative Effectiveness Research | 1 | 2024 | 713 | 0.040 |
Why?
|
Preoperative Period | 1 | 2021 | 567 | 0.040 |
Why?
|
Gender Identity | 1 | 2005 | 767 | 0.040 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2023 | 4057 | 0.040 |
Why?
|
Prostatic Neoplasms | 1 | 2021 | 11092 | 0.040 |
Why?
|
Interleukin-17 | 1 | 2024 | 921 | 0.040 |
Why?
|
Decompression, Surgical | 1 | 2023 | 603 | 0.040 |
Why?
|
Cardiac Surgical Procedures | 1 | 2023 | 3674 | 0.040 |
Why?
|
Europe | 1 | 2005 | 3427 | 0.040 |
Why?
|
Young Adult | 2 | 2018 | 59870 | 0.040 |
Why?
|
Prevalence | 1 | 2023 | 15833 | 0.030 |
Why?
|
Remission Induction | 1 | 2021 | 2409 | 0.030 |
Why?
|
Medically Uninsured | 1 | 2021 | 838 | 0.030 |
Why?
|
RNA-Binding Proteins | 1 | 2024 | 1881 | 0.030 |
Why?
|
Pulmonary Diffusing Capacity | 1 | 2015 | 93 | 0.030 |
Why?
|
Heparin | 1 | 2022 | 1632 | 0.030 |
Why?
|
Liver | 1 | 2010 | 7560 | 0.030 |
Why?
|
Trachea | 1 | 2020 | 1086 | 0.030 |
Why?
|
Longitudinal Studies | 1 | 2011 | 14751 | 0.030 |
Why?
|
Models, Animal | 2 | 2011 | 2120 | 0.030 |
Why?
|
Linear Models | 1 | 2024 | 5877 | 0.030 |
Why?
|
Suicidal Ideation | 1 | 2023 | 1465 | 0.030 |
Why?
|
Nitric Oxide Synthase | 1 | 2016 | 911 | 0.030 |
Why?
|
Consensus | 1 | 2023 | 3200 | 0.030 |
Why?
|
Carboplatin | 1 | 2016 | 789 | 0.030 |
Why?
|
Cell Cycle Proteins | 1 | 2024 | 3431 | 0.030 |
Why?
|
Coronary-Subclavian Steal Syndrome | 1 | 2012 | 2 | 0.020 |
Why?
|
Swine | 2 | 2012 | 5984 | 0.020 |
Why?
|
Endoscopy | 1 | 2020 | 1852 | 0.020 |
Why?
|
Infant | 2 | 2010 | 36377 | 0.020 |
Why?
|
Models, Biological | 1 | 2006 | 9439 | 0.020 |
Why?
|
Child, Preschool | 2 | 2011 | 42481 | 0.020 |
Why?
|
Calorimetry, Indirect | 1 | 2010 | 176 | 0.020 |
Why?
|
Forced Expiratory Volume | 1 | 2015 | 1827 | 0.020 |
Why?
|
Pulsatile Flow | 1 | 2011 | 318 | 0.020 |
Why?
|
Mitochondria, Liver | 1 | 2010 | 190 | 0.020 |
Why?
|
Heterozygote | 1 | 2016 | 2795 | 0.020 |
Why?
|
Sus scrofa | 1 | 2011 | 430 | 0.020 |
Why?
|
Comorbidity | 1 | 2024 | 10572 | 0.020 |
Why?
|
Mental Health | 1 | 2023 | 3271 | 0.020 |
Why?
|
Hospitals | 1 | 2022 | 3890 | 0.020 |
Why?
|
Systole | 1 | 2011 | 935 | 0.020 |
Why?
|
Diastole | 1 | 2011 | 785 | 0.020 |
Why?
|
Substance-Related Disorders | 1 | 2005 | 4416 | 0.020 |
Why?
|
Injections, Intravenous | 1 | 2010 | 1377 | 0.020 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2024 | 8602 | 0.020 |
Why?
|
Cell Line, Tumor | 1 | 2024 | 17060 | 0.020 |
Why?
|
Social Class | 1 | 2016 | 2009 | 0.020 |
Why?
|
Predictive Value of Tests | 2 | 2015 | 15403 | 0.020 |
Why?
|
Anticoagulants | 1 | 2022 | 4863 | 0.020 |
Why?
|
Protein Kinase Inhibitors | 1 | 2023 | 5693 | 0.020 |
Why?
|
Brain | 1 | 2023 | 27177 | 0.020 |
Why?
|
Paternal Behavior | 1 | 2006 | 33 | 0.020 |
Why?
|
Software | 1 | 2020 | 4457 | 0.020 |
Why?
|
Disease Progression | 1 | 2023 | 13615 | 0.020 |
Why?
|
Prospective Studies | 1 | 2020 | 54818 | 0.020 |
Why?
|
Mutation | 2 | 2023 | 30187 | 0.020 |
Why?
|
Alleles | 1 | 2016 | 6893 | 0.020 |
Why?
|
Depression | 1 | 2023 | 8237 | 0.010 |
Why?
|
Mice | 2 | 2024 | 81786 | 0.010 |
Why?
|
Prosthesis Design | 1 | 2011 | 2112 | 0.010 |
Why?
|
Mass Spectrometry | 1 | 2010 | 2193 | 0.010 |
Why?
|
Child | 1 | 2011 | 80510 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 2012 | 2687 | 0.010 |
Why?
|
Apoptosis | 1 | 2018 | 9511 | 0.010 |
Why?
|
Electrocardiography | 1 | 2012 | 6404 | 0.010 |
Why?
|
Stroke Volume | 1 | 2012 | 5596 | 0.010 |
Why?
|
Boston | 1 | 2010 | 9341 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2016 | 18289 | 0.010 |
Why?
|
Blood Pressure | 1 | 2011 | 8537 | 0.010 |
Why?
|
Algorithms | 1 | 2012 | 14061 | 0.010 |
Why?
|